Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet.

Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet.

Item
http://www.wikidata.org/entity/Q40578914
Use, tolerability and compliance of spironolactone in the treatment of heart failure.Risk of hyperkalemia associated with selective COX-2 inhibitors.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Adverse Drug Events Involving COX-2 Inhibitors.Pharmacotherapy in congestive heart failure: aldosterone receptor antagonism: interface with hyperkalemia in heart failure.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi ArabiaPrevalence of hyperkalemia among hemodialysis patients in Egypt.An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
P2860

Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet.

Item
http://www.wikidata.org/entity/Q40578914
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Fatal hyperkalemia related to ...... bitor and potassium rich diet.
@en
type
label
Fatal hyperkalemia related to ...... bitor and potassium rich diet.
@en
prefLabel
Fatal hyperkalemia related to ...... bitor and potassium rich diet.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Fatal hyperkalemia related to ...... bitor and potassium rich diet.
@en
P2093
P304
P31
P356
10.1016/S0736-4679(02)00434-1
P433
P478
P577
P698